Stocks to sell

In hindsight, CRISPR Therapeutics (NASDAQ:CRSP) represented a once-in-a-blue-moon opportunity during the March doldrums of last year. For a brief moment, CRSP stock slipped below $40 as the world turned its eyes on the rapidly escalating novel coronavirus pandemic. However, shares didn’t stay deflated for long as they continued to march steadily higher despite the surrounding
0 Comments
Technically, undergarment maker Naked Brand Group (NASDAQ:NAKD) is one of the best performers of the year so far. Since January’s opening session, NAKD stock has delivered both longtime shareholders and recent speculators nearly 300%. Source: Shutterstock That’s a bonkers figure, one that takes away some of the pain associated with this investment, depending on when
0 Comments